drugset
drugset / Trial / NCT02477527

Atripla to Stribild Switch Study to Evaluate Sleep Disturbances

NCT02477527 ↗

Phase 4 Completed 21 enrolled Midtown Medical Center, Tampa, FL Gilead Sciences · collab
NaSingle-groupOpen-labelTreatment

Summary

Switch patients from Atripla to Stribild will be evaluated to see if patients have less sleep disturbances.

Timeline

Start
2015-02
Primary completion
2015-12
Completion
2016-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Stribild Other / unclassified — —

Indications

AIDS sleep disorder